Compare HDFC Pharma And Healthcare Fund vs SBI Healthcare Opportunities Fund
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.1
1.93
NAV
₹16.76
₹409.05
Fund Started
14 Sep 2023
04 Jun 1999
Fund Size
₹2030.81 Cr
₹4076.67 Cr
Exit Load
Exit load of 1%, if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
1 Year
6.49%
0.99%
3 Year
-
23.42%
5 Year
-
15.73%
Equity
98.22%
97.00%
Cash
1.78%
2.93%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 9.81% |
Divi's Laboratories Ltd. | 8.38% |
Glenmark Pharmaceuticals Ltd. | 6.62% |
Lupin Ltd. | 6.44% |
Max Healthcare Institute Ltd. | 6.36% |
Alkem Laboratories Ltd. | 6.21% |
Aster DM Healthcare Ltd. | 5.42% |
Ipca Laboratories Ltd. | 4.80% |
Anthem Biosciences Ltd. | 4.46% |
Fortis Healthcare Ltd. | 4.02% |
Sun Pharmaceutical Industries Ltd. | 10.65% |
Divi's Laboratories Ltd. | 7.55% |
Apollo Hospitals Enterprise Ltd. | 5.76% |
Max Healthcare Institute Ltd. | 4.82% |
Acutaas Chemicals Ltd. | 4.77% |
Torrent Pharmaceuticals Ltd. | 4.25% |
Lupin Ltd. | 4.23% |
Aster DM Healthcare Ltd. | 3.85% |
Biocon Ltd. | 3.59% |
Laurus Labs Ltd. | 3.48% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
14 Sep 2023
04 Jun 1999
